NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE145339 Query DataSets for GSE145339
Status Public on Feb 15, 2020
Title 19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis (Agilent-030587)
Organism Homo sapiens
Experiment type Genome variation profiling by array
Summary Genomic aberrations of neuroblastoma occurring in late childhood and adolescence are uncommon and still underestimated.
Public DNA copy number profiles of 556 tumors (discovery set) and of 208 tumors obtained by array-CGH assay (validation set) were used to verify if 19p loss is significantly over-represented in children and adolescents. The 19p loss occurrence was separately tested within different age groups in the discovery and validation set and the resulting P values were combined and corrected by Bonferroni’s method.
In both sets, the lowest age group significantly associated with 19p loss (discovery set: 20%; validation set: 35%) was 6 years. The 19p loss was considered to be a significant marker for overall survival in patients over 6 years of age. Relevant tumor suppressor genes (KEAP1, DNM2, SMARCA4, SLC44A2 and CDKN2D) and microRNAs (miR-181c, miR-27a, and mirR-199a-1) were in 19p loss. Down-regulation of DNM2, SLC44A2 and CDKN2D associated with poor patient outcome and older age. Among the recurrent NB chromosomal aberrations, only 1q gain was enriched in patients older than 6 years and was mutually exclusive respect to 19p loss.
Our data demonstrate that 19p loss is a genomic biomarker of NBs diagnosed in older children that can predict clinical outcome.
 
Overall design This study includes 208 neuroblastoma tumors obtained by array-CGH assay were used to verify if 19p loss is significantly over-represented in children and adolescents.
This subseries includes 62 neuroblastoma tumors analyzed on Agilent-030587.
 
Contributor(s) Pezzolo A
Citation(s) 32337068
Submission date Feb 14, 2020
Last update date May 19, 2020
Contact name Annalisa Pezzolo
E-mail(s) annalisapezzolo@gaslini.org
Organization name IRCCS Istituto Gaslini
Lab Laboratorio Cellule Staminali e Terapie Cellulari
Street address Via Gerolamo Gaslini, 3
City Genova
ZIP/Postal code 16147
Country Italy
 
Platforms (1)
GPL16237 Agilent-030587 CCMC CGH plus SNP 180k Microarray
Samples (62)
GSM4315123 neuroblastoma sample 3
GSM4315124 neuroblastoma sample 18
GSM4315125 neuroblastoma sample 23
This SubSeries is part of SuperSeries:
GSE145341 19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis
Relations
BioProject PRJNA606783

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE145339_RAW.tar 1.2 Gb (http)(custom) TAR (of TXT)
GSE145339_data_matrix_GPL16237.txt.gz 63.0 Mb (ftp)(http) TXT
Processed data included within Sample table
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap